Renovacor
Magdalene Cook, MD, is the President and Chief Executive Officer of Renovacor. Dr. Cook has over 20 years of experience in the life sciences industry primarily in investing, consulting and launching new ventures. Previously she worked as an investment professional at Aisling Capital, and served on the board of directors of companies in the life sciences and diagnostics industry.
Dr. Cook received a MD from Columbia University College of Physicians & Surgeons and a BA in Interdisciplinary Studies from the University of Virginia, where she was an Echols Scholar.
This person is not in any offices
Renovacor
Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system (“CNS”) diseases resulting from BAG3 gene variants, today announced the appointment of Marc Semigran, M.D., as chief medical officer of Renovacor.